Global Intracranial Stents Industry - KHGI-TV/KWNB-TV/KHGI-CD-Grand Island, Kearney, Hastings

Global Intracranial Stents Industry

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker



 

 

 

NEW YORK, June 3, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Intracranial Stents Industry

http://www.reportlinker.com/p01658726/Global-Intracranial-Stents-Industry.html

This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands.

The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a five-year historic analysis is provided for these markets.

The report profiles 16 companies including many key and niche players such as Admedes Schuessler GmbH, BALT Extrusion, Cardiatis SA, Codman & Shurtleff, Inc., Covidien PLC, ITGI Medical Ltd., Medtronic, Inc., MicroPort Scientific Corporation, OBEX Medical, Penumbra, Inc., and Stryker Corporation.

Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs.



I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
A Prelude II-1
Recession in Retrospect and the Road Ahead II-1

2. MARKET DRIVERS, ISSUES & CHALLENGES II-3
US FDA Restrictions on Use of Stryker's Wingspan: A Major Blow
to ICAD Stents Market II-3
Aging Population to Propel Growth in Intracranial Stents Market II-4
Table 1: Elderly Population (65+ Years) as a Percentage of
the Total Population: 2000 & 2025 (includes corresponding
Graph/Chart) II-4

Table 2: Global Population Statistics for the 65+ Age Group:
2012 (includes corresponding Graph/Chart) II-5
Changing Lifestyle Conditions Stoking Risk of Cerebrovascular
Diseases II-6
Startling Statistics of Stroke II-6
Rising Number of Restenosis Cases Boosts Demand for Stenting II-7
Asians at Highest Risk of Intracranial Atherosclerosis Disease II-7
Cardiovascular Stent Manufacturers Diversify Into the
Neurovascular Market II-7
QMRA Facilitates Detection of In-stent Stenosis II-8
MNCs Weave Strategies to Tap Growth Centers in Emerging Markets II-8
Medical Tourism Buoys Demand for Stenting Procedures in
Emerging Nations II-9
Challenges in Product Development and Commercialization
Moderate Market Growth II-9
Technological Challenges II-10
Safety and Efficacy II-10
Regulatory Challenges II-10
Price Factor II-10
Rising Road Accidents Lead to Increasing Number of Stenting
Procedures II-10
Table 3: Global Rate of Road Fatalities by Economic Status of
Countries (2013): Percentage Rate of Road Fatalities per
100,000 Residents for Low, Mid and High Per Capita Income
Regions (includes corresponding Graph/Chart) II-11

3. PRODUCT OVERVIEW II-12
Intracranial Stents II-12
Intracranial Stenting II-12
Glossary of Physical Characteristics of Stents II-12
Evolution II-13
Types of Stents II-13
Bare Metal Stents (BMS) II-13
Drug Eluting Stents II-14
Self-Expanding Stents II-14
A Brief Review of the Intracranial Stenting Systems Available
in the Marketplace II-15
Neuroform II-15
Neuroform EZ® Stent System II-15
Wingspan Stent System II-15
SELF-EXPANDAPLE LEO II-16
Micrus® Pharos™ Vitesse™ Intracranial Stent II-16
Neurolink System® II-17
Solitaire™ FR Revascularization Device II-17
Solitaire AB Neurovascular Remodeling Device II-17
Cordis Enterprise Vascular Reconstruction Device and Delivery
System II-17
The Pipeline Stent II-17
Other Procedures II-18
Flow Diverters II-18
Silk™ II-18
Pipeline Embolization Device (PED) II-18
Post-Treatment Management II-18
Anti-Platelet Therapy II-18
Surveillance Imaging II-19

4. NEUROVASCULAR DISEASES - AN OVERVIEW II-20
Introduction II-20
Ischemic Stroke II-20
Symptoms, Indications and Complications Associated with Strokes II-20
Posterior Circulation Strokes II-20
Anterior Circulation Strokes II-20
Non-Specific Signs II-21
Complications II-21
Some Major Risk Factors of Strokes II-21
Intracranial Stenosis II-22
Diagnosis of Intracranial Stenosis II-22
Differential Diagnosis II-22
Screening II-23
Anatomic Diagnosis II-23
Digital Subtraction Angiography II-23
Transcranial Doppler II-23
Magnetic Resonance Angiography (MRA) II-23
Positron Emission Tomography (PET) II-24
Computerized Tomography (CT) Perfusion II-24
Treatment Procedures for Intracranial Stenosis II-24
Medication II-24
Anticoagulants or Blood Thinners II-24
Cholesterol Lowering Drugs II-24
Blood Pressure Medications II-24
Surgical Procedures II-25
Stenting/Balloon Angioplasty II-25
Cerebral Artery Bypass II-25
Major Neurovascular Indications Requiring Stenting Procedures II-25
Intracranial Atherosclerotic Disease (ICAD) II-25
Risk Factors II-26
Treatment Options for ICAD II-26
Brain Aneurysms/ Cerebral Aneurysm/ Intracranial Aneurysm II-26
Aneurysm - Quick Facts II-26
Symptoms of Unruptured Aneurysm II-27
Risk Factors for Aneurysm II-27
Detection Methods II-27
Table 4: Comparison of Sensitivity and Specificity of
Computed Tomography Angiography (CTA), Transcranial Doppler
Sonography (TCD) and Magnetic Resonance Angiography (MRA)
in the Diagnosis of Intracranial Aneurysms (includes
corresponding Graph/Chart) II-28

Table 5: Percentage Mortality, Morbidity and Re-bleeding
Rate of Intervention Associated with Intracranial Aneurysms II-28
Arterial Dissections II-28
Diagnosis II-29
Treatment II-29
Restenosis II-29

5. PRODUCT INTRODUCTIONS & APPROVALS II-30
MicroPort's WILLIS® Intracranial Stent Graft System Receives
China SFDA Approval II-30
Phenox's pCONus Bifurcation Aneurysm Implant Obtains CE-Mark
Approval II-30
Acandis' Acclino 1.9-F Stent System Receives CE Mark Approval II-30
ITGI Medical Obtains CE Mark Approval for AneuGraftNx II-31
Micrus Endovascular Obtains FDA Approval for VISSIT Clinical
Trial II-31
Reverse Medical Obtains CE Mark for ReFlex A+ Catheter II-31
Boston Scientific Introduces Neuroform EZ™ Stent System II-32
Codman & Shurtleff Obtains Approval for Vascular
Reconstruction Device and Delivery System in Japan II-32
Reverse Medical Obtains CE Mark Approval for RePort Guide
Catheter System II-32

6. RECENT INDUSTRY ACTIVITY II-33
STAR Study Results Establish Safety and Efficacy of Solitaire™
FR Device in Acute Ischemic Stroke Treatment II-33
MicroPort Scientific Announces Inauguration of MicroPort
NeuroTech II-33
Admedes Schuessler to Expand Nitinol Manufacturing Capacity II-33
Purdue University Scientists Study Stents Coated with
Nanotechnology-Enhanced Drug for Treatment of Aneurysms II-34
Boston Scientific Divests Neurovascular Business to Stryker II-34
NeuroSigma and UCLA Enter into Exclusive License Contract II-34
Johnson & Johnson Takes Over Micrus Endovascular II-35
Covidien Takes Over ev3 II-35
Bayer MaterialScience Completes Acquisition of PolyBioMed II-35

7. FOCUS ON SELECT PLAYERS II-37
Admedes Schuessler GmbH (Germany) II-37
BALT Extrusion (France) II-37
Cardiatis SA (Belgium) II-37
Codman & Shurtleff, Inc. (US) II-38
Covidien PLC (Ireland) II-38
ITGI Medical Ltd. (Israel) II-39
Medtronic, Inc. (US) II-40
MicroPort Scientific Corporation (China) II-40
OBEX Medical (New Zealand) II-40
Penumbra, Inc. (US) II-41
Stryker Corporation (US) II-41

8. GLOBAL MARKET PERSPECTIVE II-43
Table 6: World Recent Past, Current & Future Analysis for
Intracranial Stents by Geographic Region - US, Europe and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for the Years 2010 through 2018
(includes corresponding Graph/Chart) II-43

Table 7: World Historic Review for Intracranial Stents by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for the Years 2005 through 2009 (includes
corresponding Graph/Chart) II-44

Table 8: World 14-Year Perspective for Intracranial Stents by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for the Years 2005, 2013 &
2018 (includes corresponding Graph/Chart) II-45


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Regulatory Status of Intracranial Stents in the United States III-1
Intracranial Stenting among Medicare Beneficiaries during
the Years 2006-2010 III-1
Product Introductions & Approvals III-1
Strategic Corporate Developments III-2
Key Players III-4
B.Market Analytics III-6
Table 9: US Recent Past, Current & Future Analysis for
Intracranial Stents Market Analyzed with Annual Sales
Figures in US$ Thousand for the Years 2010 through 2018
(includes corresponding Graph/Chart) III-6

Table 10: US Historic Review for Intracranial Stents Market
Analyzed with Annual Sales Figures in US$ Thousand for the
Years 2005 through 2009 (includes corresponding Graph/Chart) III-6

2. EUROPE III-7
A.Market Analysis III-7
Current and Future Analysis III-7
European Neurosurgicals Market Poised to Grow At a Slow Pace III-7
Focus on Select Regional Markets III-7
France III-7
French Government Imposes Regulations on Advertisement of
High-risk Medical Devices III-7
The United Kingdom III-8
Stroke Statistics in the UK III-8
Table 11: Breakdown of Total Number of Deaths Due to
Strokes by Age and Sex in the UK for the Year 2010
(includes corresponding Graph/Chart) III-8
Product Introductions & Approvals III-9
Strategic Corporate Developments III-10
Key Players III-11
B.Market Analytics III-13
Table 12: European Recent Past, Current & Future Analysis
for Intracranial Stents Market Analyzed with Annual Sales
Figures in US$ Thousand for the Years 2010 through 2018
(includes corresponding Graph/Chart) III-13

Table 13: European Historic Review for Intracranial Stents
Market Analyzed with Annual Sales Figures in US$ Thousand
for the Years 2005 through 2009 (includes corresponding
Graph/Chart) III-14

3. REST OF WORLD III-15
A.Market Analysis III-15
Current and Future Analysis III-15
Price Sensitivity of Asian Consumers Hinders Market Growth III-15
Focus on Select Regional Markets III-15
Australia III-15
Pertinent Stroke-related Statistics in Australia III-15
Table 14: Stroke Prevalence in Australia by Age and
Gender for the Year 2012 (includes corresponding
Graph/Chart) III-15
Leading Risk Factors Responsible for Stroke-Related
Fatalities Ranked on the Basis of Number of Deaths (2012) III-16
China III-16
Healthcare Reforms to Propel Stent Market III-16
Table 15: Leading Brands in the Chinese Intracranial
Stents Market (2012): Percentage Breakdown of Market
Share for Apollo and Others (includes corresponding
Graph/Chart) III-16
WILLIS® to Target Bright Market Prospects in China III-16
India III-17
Stroke 'At a Glance' III-17
Changes in Lifestyle Demographic and Socioeconomic Factors
Increase Stroke Prevalence III-17
Management and Treatment of Stroke Presents a Daunting Task III-17
Kerala - The New Global Hub for Neurovascular Therapy III-18
Japan III-18
Studies Validate Effectiveness of Endovascular Therapy for
Treatment of Intracranial Aneurysm III-18
Factors Impacting Japanese Intracranial Stents Market III-19
Product Introductions & Approvals III-19
Strategic Corporate Development III-21
Key Players III-21
B.Market Analytics III-23
Table 16: Rest of World Recent Past, Current & Future
Analysis for Intracranial Stents Market Analyzed with Annual
Sales Figures in US$ Thousand for the Years 2010 through
2018 (includes corresponding Graph/Chart) III-23

Table 17: Rest of World Historic Review for Intracranial
Stents Market Analyzed with Annual Sales Figures in US$
Million for the Years 2005 through 2009 (includes
corresponding Graph/Chart) III-24


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 16 (including Divisions/Subsidiaries - 18)

The United States (7)
Europe (6)
- France (1)
- Germany (3)
- Rest of Europe (2)
Asia-Pacific (Excluding Japan) (4)
Middle East (1)



To order this report: Global Intracranial Stents Industry
http://www.reportlinker.com/p01658726/Global-Intracranial-Stents-Industry.html



__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

 

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
General and news information or questions:
Across the Midlands Information:
events@nebraska.tv
Comments: comments@nebraska.tv
News:
news@nebraska.tv
Phone: 308-743-2494
News Fax: 308-743-2660
All content © Copyright 2000 - 2014 WorldNow and NTV. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.